Business Wire

MULTIBANK-GROUP

7.5.2024 15:28:28 CEST | Business Wire | Press release

Share
MultiBank Group Honored as Best Gold Broker of 2024 by FX Empire

MultiBank Group, a premier forex broker, has proudly received the prestigious accolade of "Best Gold Broker 2024" from FX Empire, a globally acclaimed financial news portal known for its accurate forecasts, comprehensive market insights, detailed broker evaluations, and up-to-the-minute news coverage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240507590160/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

MultiBank Group Honored as Best Gold Broker of 2024 by FX Empire (Graphic: Business Wire)

Established in 2005 in California, USA, MultiBank Group has amassed an impressive collection of over 50 awards. Recognized worldwide as a top-tier broker, MultiBank Group offers a diverse portfolio of more than 20,000 instruments across six asset classes, including forex, metals, indices, shares, cryptocurrencies, and stocks.

This recognition from FX Empire underscores the exceptional quality of service provided by MultiBank Group to its clientele, who rely on the broker for gold trading—an asset that has seen significant growth and value appreciation in recent times. This acknowledgment reaffirms MultiBank Group's longstanding reputation, extensive experience, and unwavering professionalism in the industry.

With the launch of its cutting-edge mobile application, MultiBank Plus, clients can enjoy lightning-fast access to a wide array of assets, along with advanced trading tools for optimal performance. Offering competitive features such as low spreads, leverage of up to 500:1, and multiple payment methods free from internal charges or commissions, MultiBank Group ensures an unparalleled trading experience for its users.

Serving over 1,000,000 clients globally and maintaining more than 25 offices worldwide, MultiBank Group stands as a premier choice for both novice traders and seasoned investors, providing tailored solutions to meet diverse investment needs.

About MultiBank Group:

MultiBank Group is a leading financial institution with a paid-up capital exceeding US $322 million and a daily average trading volume of $12.1 billion. With over 14 regulatory licenses across the globe, MultiBank Group is widely regarded as one of the most regulated and trusted brokers in the industry. For more information, please visit https://multibankfx.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507590160/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Investment Is Surging, but Businesses Are Struggling to Prove the Value, HTEC Global Study Finds15.10.2026 10:42:00 CEST | Press release

Research among 1,500 C-suite executives finds 77% believe people and processes now constrain AI value more than technology HTEC, a global product engineering and AI transformation company, today launches The HTEC AI Value Realization Report 2026, revealing a new challenge emerging as organizations move beyond AI experimentation: investment is accelerating faster than many companies’ ability to measure, govern and consistently realize its value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015407055/en/ HTEC, a global product engineering and AI transformation company, today launches The HTEC AI Value Realization Report 2026, revealing a new challenge emerging as organizations move beyond AI experimentation: investment is accelerating faster than many companies’ ability to measure, govern and consistently realize its value. The independent study finds that 79% of organizations have increased AI investment over the past ye

Too Good To Go Expands Its Marketplace Beyond Food15.10.2026 09:30:00 CEST | Press release

Too Good To Go, the world's largest marketplace for surplus food, today announced that it is expanding its Marketplace beyond food, enabling retailers to redistribute surplus across personal care — including skincare, haircare, oral care and beauty products — pet care, flowers and plants, nutrition and supplements, and home, initially spanning cleaning and laundry products and décor. More than 8,500 stores already supply products across these areas, around one third of which were already working with Too Good To Go to redistribute surplus food. “In today’s society, we have built incredibly efficient processes for producing and selling things at scale, creating abundance, but we have not built the same efficiency into making sure what is left over gets used. As our lives have become more convenient, we have become less conscious of what those things are worth. We used to finish what was on the plate, find a use for what we had and instinctively pause before throwing something away. Too

Flowdesk Europe Receives Payment Institution Authorization from the ACPR Under PSD215.10.2026 09:30:00 CEST | Press release

The authorization allows Flowdesk Europe to provide custody and transfer services for fiat-denominated stablecoins, complementing its MiCA CASP authorization and regulated offering for European clients. Flowdesk, a global liquidity provider and digital asset trading and infrastructure provider, today announced that its European entity, Flowdesk Europe, has been authorized as a Payment Institution by the French Prudential Supervision and Resolution Authority, l'Autorité de contrôle prudentiel et de résolution (ACPR), under the second Payment Services Directive (PSD2). The authorization allows Flowdesk Europe to provide custody and transfer services for e-money tokens (EMTs), the fiat-referenced stablecoins regulated under the Markets in Crypto-Assets (MiCA) regulation, to its clients across the European Union. The authorization follows the entity’s Crypto-Asset Service Provider (CASP) authorization received from the Autorité des Marchés Financiers (AMF) under MiCA at the end of June thi

From AI to Autonomous Networks: Mobileum Spark Highlights the Next Frontier of Telecom Intelligence15.10.2026 09:00:00 CEST | Press release

Industry leaders get together to explore how trusted AI, Agentic Intelligence and automation are transforming risk management, accelerating autonomous network operations and unlocking new opportunities for value creation Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics and network solutions, brought together telecom operators and industry leaders during its Mobileum Spark events series in Lisbon (Portugal) and Frankfurt (Germany), to explore how Artificial Intelligence (AI), Agentic AI and automation are transforming network operations and accelerating the evolution toward autonomous networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015172815/en/ Telecom operators, industry leaders, and Mobileum experts at Mobileum Spark 2026. Focused on Risk Management & Fraud Prevention and Network Testing & Assurance, the events featured customer-led discussions, expert insights, and real-world use case

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release

Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye